Pediatric Priority Review Voucher Designations Near 30; How Many Can Beat Sunset Date?
This article was originally published in RPM Report
FDA has designated 29 products under the rare pediatric disease incentive program – all with the potential to win a voucher for a priority review of another product. That means two dozen products are racing the clock ahead of the September 30 sunset date for the program.
You may also be interested in...
Surge of interest prompts US FDA to consider how to adjust feedback, including potentially creating a separate team to answer more basic questions.
When the closest you can get to US FDA staff is Webex, the meeting minutes and interactions with the review team project manager take on increased importance, consultants suggest during an Informa-sponsored webinar.
Amid the COVID-19 pandemic, Richard Pazdur doesn’t want the cancer patient forgotten. His solution: keep churning out approvals.